Recent success has been achieved in Alzheimer’s disease (AD) therapeutics targeting amyloid beta (Aβ), demonstrating a significant reduction in rates of cognitive decline. However, testing methods for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results